EA

Eric Anschutz

North America, Texas, United States, Austin

Description

Eric Anschutz - Board of Directors @ JamBase

Investor Profile

Eric Anschutz has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Angel (50%)
  • Seed (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Nanotechnology
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Eric Anschutz frequently co-invest with?

Kauffman Fellows
North America, California, United States, Palo Alto
Co-Investments: 1
Zoic Capital
North America, Washington, United States, Bellevue
Co-Investments: 1
Techammer
North America, New York, United States, New York
Co-Investments: 1

Which angels does Eric Anschutz often collaborate with?

JR
North America, California, United States, San Francisco
Shared Deals: 1
TK
North America, California, United States, Belmont
Shared Deals: 1
ED
North America, New York, United States, New York
Shared Deals: 1
JY
North America, California, United States, San Francisco
Shared Deals: 1
D.A. Wallach
North America, California, United States, Los Angeles
Shared Deals: 1
JH
North America, United States
Shared Deals: 1
MS
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Eric Anschutz?

HDT Bio

Seattle, Washington, United States

HDT Bio is a developer of RNA vaccines and therapeutics based on LION formulation technology.

BiopharmaBiotechnologyPharmaceutical
SeedOct 5, 2020
Amount Raised: $4,000,000
Ligandal

Brooklyn, New York, United States

Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.

BiotechnologyGeneticsNanotechnology
AngelAug 9, 2016
Amount Raised: $330,000